BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17409946)

  • 1. Temozolomide as prophylaxis for brain metastasis in non-small cell lung cancer.
    Robins HI; Traynor AM; Mehta M
    J Thorac Oncol; 2006 Sep; 1(7):732-3; author reply 733. PubMed ID: 17409946
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiochemotherapy for brain metastasis: how to define a role for temozolomide.
    Weller M
    Onkologie; 2007 Jul; 30(7):350-1. PubMed ID: 17596741
    [No Abstract]   [Full Text] [Related]  

  • 3. [Protracted low-dose temozolomide combined with concomitant whole brain radiotherapy for brain metastases from non-small cell lung cancer].
    Liu ZF; Li HQ; Tao RJ
    Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):792-3. PubMed ID: 22335916
    [No Abstract]   [Full Text] [Related]  

  • 4. Leptomeningeal metastases from small cell lung cancer responsive to temozolomide therapy.
    Zauderer M; Krug LM; Pietanza MC; O'Rourke D
    J Thorac Oncol; 2010 Oct; 5(10):1716-7. PubMed ID: 20871272
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral temozolomide in heavily pre-treated brain metastases from non-small cell lung cancer: phase II study.
    Giorgio CG; Giuffrida D; Pappalardo A; Russo A; Santini D; Salice P; Blanco G; Castorina S; Failla G; Bordonaro R
    Lung Cancer; 2005 Nov; 50(2):247-54. PubMed ID: 16039010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temozolomide for treating brain metastases.
    Abrey LE; Christodoulou C
    Semin Oncol; 2001 Aug; 28(4 Suppl 13):34-42. PubMed ID: 11550137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of temozolomide combined with irinotecan is partly independent of O6-methylguanine-DNA methyltransferase and mismatch repair phenotypes in xenograft models.
    Houghton PJ; Stewart CF; Cheshire PJ; Richmond LB; Kirstein MN; Poquette CA; Tan M; Friedman HS; Brent TP
    Clin Cancer Res; 2000 Oct; 6(10):4110-8. PubMed ID: 11051264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of brain metastases of malignant melanoma with temozolomide.
    Biasco G; Pantaleo MA; Casadei S
    N Engl J Med; 2001 Aug; 345(8):621-2. PubMed ID: 11529230
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of temozolomide with other cytotoxic chemotherapy in the treatment of patients with recurrent brain metastases from lung cancer.
    Ebert BL; Niemierko E; Shaffer K; Salgia R
    Oncologist; 2003; 8(1):69-75. PubMed ID: 12604733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temozolomide as prophylaxis for melanoma brain metastases.
    Conill C; González-Cao M; Jorcano S; Puig S; Malvehy J; Martí R; Castel T
    Melanoma Res; 2004 Feb; 14(1):73-4. PubMed ID: 15091198
    [No Abstract]   [Full Text] [Related]  

  • 11. Schedule-dependent activity of temozolomide plus CPT-11 against a human central nervous system tumor-derived xenograft.
    Patel VJ; Elion GB; Houghton PJ; Keir S; Pegg AE; Johnson SP; Dolan ME; Bigner DD; Friedman HS
    Clin Cancer Res; 2000 Oct; 6(10):4154-7. PubMed ID: 11051270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965).
    Dziadziuszko R; Ardizzoni A; Postmus PE; Smit EF; Price A; Debruyne C; Legrand C; Giaccone G;
    Eur J Cancer; 2003 Jun; 39(9):1271-6. PubMed ID: 12763216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does addition of temozolomide to whole brain radiotherapy improve outcome in patients with brain metastases?
    Erridge SC; Gregor A
    Nat Clin Pract Oncol; 2005 Apr; 2(4):194-5. PubMed ID: 16264933
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel chemotherapeutic agents for the treatment of glioblastoma multiforme.
    Jendrossek V; Belka C; Bamberg M
    Expert Opin Investig Drugs; 2003 Dec; 12(12):1899-924. PubMed ID: 14640936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapy for brain metastases].
    Narita Y
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():639-44. PubMed ID: 16201593
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiple cerebral hemorrhagic foci from metastases during temozolomide treatment in a patient with corticotroph pituitary carcinoma.
    Mendola M; Passeri E; Ambrosi B; Corbetta S
    J Clin Endocrinol Metab; 2014 Aug; 99(8):2623-4. PubMed ID: 24823463
    [No Abstract]   [Full Text] [Related]  

  • 17. Solitary brain metastasis as first manifestation of small-cell parotid gland carcinoma with high sensitivity to temozolomide therapy on basis of tumor O6-methylguanine-DNA-methyltransferase expression.
    Lolli I; Morra I; Cimmino A; Trevisan E; Rudà R; Piombino M; Campanella G; Gillio Tos A; De Marco L; Trevisan M; Fiano V; Soffietti R
    J Clin Oncol; 2013 Aug; 31(23):e394-7. PubMed ID: 23796990
    [No Abstract]   [Full Text] [Related]  

  • 18. The efficacy of CCNU in non-small cell lung carcinoma presenting with cranial metastases.
    Celik I; Erman M; Kars A; Tekuzman G
    J Exp Clin Cancer Res; 1998 Sep; 17(3):375. PubMed ID: 9894779
    [No Abstract]   [Full Text] [Related]  

  • 19. [Complete response of cerebral metastasic melanoma after a combined treatment of radiotherapy and temozolomide].
    Conill C; Puig S; Toscas I; Castel T
    Med Clin (Barc); 2002 Nov; 119(19):758-9. PubMed ID: 12487980
    [No Abstract]   [Full Text] [Related]  

  • 20. Prophylactic cranial irradiation versus observation in stage III non-small-cell lung cancer.
    Gore E
    Clin Lung Cancer; 2006 Jan; 7(4):276-8. PubMed ID: 16512983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.